ENTRY       D00181                      Drug
NAME        Argatroban (USP);
            Argatroban hydrate (JP18);
            Novastan (TN)
PRODUCT     ARGATROBAN (Accord Healthcare)
            ARGATROBAN (Eugia US LLC)
            ARGATROBAN (Fresenius Kabi USA)
            ARGATROBAN (Hikma Pharmaceuticals USA)
            ARGATROBAN (Hikma Pharmaceuticals USA)
            ARGATROBAN (Hikma Pharmaceuticals USA)
  GENERIC   ARGATROBAN (Amneal Pharmaceuticals LLC)
            ARGATROBAN (Caplin Steriles Limited)
            ARGATROBAN (Fresenius Kabi USA)
            ARGATROBAN (Gland Pharma Limited)
            ARGATROBAN (Gland Pharma Limited)
            ARGATROBAN (Hospira)
            ARGATROBAN (Mylan Institutional LLC)
            ARGATROBAN (Par Pharmaceutical)
            ARGATROBAN (Par Pharmaceutical)
            ARGATROBAN (Sagent Pharmaceuticals)
FORMULA     C23H36N6O5S. H2O
EXACT_MASS  526.2574
MOL_WEIGHT  526.6494
CLASS       Blood modifier agent
             DG01950  Antithrombotic agent
              DG01511  Thrombin inhibitor
            Metabolizing enzyme substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
REMARK      Therapeutic category: 2190
            ATC code: B01AE03
            Chemical structure group: DG00163
            Product (DG00163): D00181<JP/US>
EFFICACY    Anticoagulant, Thrombin inhibitor
COMMENT     Direct thrombin inhibitor
TARGET      F2 [HSA:2147] [KO:K01313]
  PATHWAY   hsa04080(2147)  Neuroactive ligand-receptor interaction
            hsa04610(2147)  Complement and coagulation cascades
METABOLISM  Enzyme: CYP3A4 [HSA:1576]
INTERACTION  
STR_MAP     map07049  Antithrombosis agents
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             B BLOOD AND BLOOD FORMING ORGANS
              B01 ANTITHROMBOTIC AGENTS
               B01A ANTITHROMBOTIC AGENTS
                B01AE Direct thrombin inhibitors
                 B01AE03 Argatroban
                  D00181  Argatroban (USP) &lt;JP/US&gt;
            Therapeutic category of drugs in Japan [BR:br08301]
             2  Agents affecting individual organs
              21  Cardiovascular agents
               219  Miscellaneous
                2190  Miscellaneous
                 D00181  Argatroban (USP); Argatroban hydrate (JP18)
            Drug groups [BR:br08330]
             Blood modifier agent
              DG01950  Antithrombotic agent
               DG01511  Thrombin inhibitor
                DG00163  Argatroban
                 D00181  Argatroban
             Metabolizing enzyme substrate
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG00163  Argatroban
                 D00181  Argatroban
            Target-based classification of drugs [BR:br08310]
             Enzymes
              Hydrolases (EC3)
               Serine peptidases
                F2
                 D00181  Argatroban (USP) &lt;JP/US&gt;
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00181  Argatroban hydrate
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D00181
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D00181
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D00181
            Drug groups [BR:br08330]
             Blood modifier agent
              DG01950  Antithrombotic agent
               DG01511  Thrombin inhibitor
                DG00163  Argatroban
             Metabolizing enzyme substrate
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG00163  Argatroban
DBLINKS     CAS: 141396-28-3
            PubChem: 7847249
            LigandBox: D00181
ATOM        36
            1   C8y C    18.1598  -18.5916
            2   C8y C    16.9465  -17.8857
            3   C8y C    18.1539  -19.9972
            4   N1x N    19.3788  -17.8917
            5   S4a S    16.9525  -16.4919
            6   C8x C    15.7334  -18.5916
            7   C8x C    16.9465  -20.6912
            8   C1x C    19.3672  -20.6971
            9   C1x C    20.5919  -18.6033
            10  N1b N    18.1598  -15.7977
            11  O3c O    15.7451  -15.7919
            12  O3c O    18.2299  -17.2727
            13  C8x C    15.7334  -19.9972
            14  C1y C    20.5862  -20.0088
            15  C1c C    18.1598  -14.4037
            16  C1a C    21.7877  -20.7088
            17  C5a C    19.3729  -13.7038
            18  C1b C    16.9525  -13.7038
            19  N1y N    20.5803  -14.4037
            20  O5a O    19.3729  -12.3100
            21  C1b C    15.7451  -14.3980
            22  C1y C    21.7819  -13.7038
            23  C1x C    20.5687  -15.7919
            24  C1b C    14.5378  -13.6981
            25  C1x C    22.9893  -14.4037
            26  C6a C    21.7819  -12.3100
            27  C1x C    21.7760  -16.4919
            28  N1b N    13.3305  -14.3980
            29  C1y C    22.9893  -15.7977
            30  O6a O    22.9893  -11.6101
            31  O6a O    20.5687  -11.6101
            32  C2c C    12.1230  -13.6981
            33  C1a C    24.1964  -16.4976
            34  N1a N    10.9099  -14.3920
            35  N2a N    12.1230  -12.2984
            36  O0  O    26.4235  -19.0021
BOND        37
            1     1   2 1
            2     1   3 2
            3     1   4 1
            4     2   5 1
            5     2   6 2
            6     3   7 1
            7     3   8 1
            8     4   9 1
            9     5  10 1
            10    5  11 2
            11    5  12 2
            12    6  13 1
            13    8  14 1
            14   15  10 1 #Up
            15   14  16 1
            16   15  17 1
            17   15  18 1
            18   17  19 1
            19   17  20 2
            20   18  21 1
            21   19  22 1
            22   19  23 1
            23   21  24 1
            24   22  25 1
            25   22  26 1 #Up
            26   23  27 1
            27   24  28 1
            28   25  29 1
            29   26  30 1
            30   26  31 2
            31   28  32 1
            32   29  33 1 #Down
            33   32  34 1
            34   32  35 2
            35    7  13 2
            36    9  14 1
            37   27  29 1
///
